Hepatic Transarterial Administrations of NKR-2 in Patients With Unresectable Liver Metastases From Colorectal Cancer

NCT03370198 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class

Stopped Difficulties in patient recruitment and clinical strategy modification based on new clinical data generated in the NKR-2 early development.

Conditions

Interventions

Sponsor

Celyad Oncology SA